Current perspectives of the applications of polyphenols and flavonoids in cancer therapy
X Montané, O Kowalczyk, B Reig-Vano, A Bajek… - Molecules, 2020 - mdpi.com
The development of anticancer therapies that involve natural drugs has undergone
exponential growth in recent years. Among the natural compounds that produce beneficial …
exponential growth in recent years. Among the natural compounds that produce beneficial …
Apigenin in cancer prevention and therapy: a systematic review and meta-analysis of animal models
Background Apigenin is being increasingly recognized as a cancer chemopreventive agent.
We aimed to investigate the anticancer effects of Apigenin in in-vivo studies to know its …
We aimed to investigate the anticancer effects of Apigenin in in-vivo studies to know its …
Therapeutical properties of apigenin: A review on the experimental evidence and basic mechanisms
ABSTRACT Apigenin (4,'5, 7-trihydroxyflavone) is one of the most studied flavonoids with
low toxicity and abundantly present phenolic compound in the plant kingdom. The main …
low toxicity and abundantly present phenolic compound in the plant kingdom. The main …
Revisiting inorganic nanoparticles as promising therapeutic agents: A paradigm shift in oncological theranostics
Cancer remains a global health problem largely due to a lack of effective therapies. Major
cancer management strategies include chemotherapy, surgical resection, and radiation …
cancer management strategies include chemotherapy, surgical resection, and radiation …
Recent advancement in bioeffect, metabolism, stability, and delivery systems of apigenin, a natural flavonoid compound: challenges and perspectives
P Chen, F Chen, ZL Guo, J Lei, B Zhou - Frontiers in Nutrition, 2023 - frontiersin.org
Apigenin is a bioflavonoid compound that is widely present in dietary plant foods and
possesses biological activities that protect against immune, cardiovascular, and …
possesses biological activities that protect against immune, cardiovascular, and …
Apigenin analogues as SARS-CoV-2 main protease inhibitors: In-silico screening approach
A Farhat, H Ben Hlima, B Khemakhem… - …, 2022 - Taylor & Francis
The COVID-19 new variants spread rapidly all over the world, and until now scientists strive
to find virus-specific antivirals for its treatment. The main protease of SARS-CoV-2 (Mpro) …
to find virus-specific antivirals for its treatment. The main protease of SARS-CoV-2 (Mpro) …
Unveiling the therapeutic promise of natural products in alleviating drug‐induced liver injury: Present advancements and future prospects
Drug‐induced liver injury (DILI) refers to adverse reactions to small chemical compounds,
biological agents, and medical products. These reactions can manifest as acute or chronic …
biological agents, and medical products. These reactions can manifest as acute or chronic …
Accentuating CircRNA-miRNA-transcription factors axis: a conundrum in cancer research
D Singh, P Kesharwani, NA Alhakamy… - Frontiers in …, 2022 - frontiersin.org
Circular RNAs (circRNAs) are the newly uncovered class of non-coding RNAs being
cognized as profound regulators of gene expression in developmental and disease biology …
cognized as profound regulators of gene expression in developmental and disease biology …
Apigenin alleviates cancer drug Sorafenib induced multiple toxic effects in Swiss albino mice via anti-oxidative stress
Sorafenib is an FDA-approved chemotherapeutic drug used as standard therapy for
advanced-stage cancers. However, Sorafenib-induced multiple adverse effects are a major …
advanced-stage cancers. However, Sorafenib-induced multiple adverse effects are a major …
Therapeutic implications of probiotics in microbiota dysbiosis: A special reference to the liver and oral cancers
The microbiota plays an important role in maintaining the body's homeostasis. Imbalance in
the microbiota is referred to as microbiota dysbiosis. Microbiota dysbiosis leads to pro …
the microbiota is referred to as microbiota dysbiosis. Microbiota dysbiosis leads to pro …